EP.18.04 CLOG-0004 Clinical Outcomes of Tislelizumab Combined With Chemotherapy as Induction Therapy in Stage III (cTNM-IIIB/IIIC) NSCLC
Back to course
Asset Subtitle
Ting Wang
Meta Tag
Speaker Ting Wang
Topic Clinical Trials in Progress
Powered By